Skip to main content
. Author manuscript; available in PMC: 2018 Jan 26.
Published in final edited form as: Analyst. 2017 Jan 26;142(3):442–448. doi: 10.1039/c6an02486f

Figure 2. MPLEx Inactivation of Viral Pathogens.

Figure 2

The bargraphs depict the level of pathogen inactivation after MPLEx extraction by quantifying the number of Focus Forming Units (FFU) or Plaque Forming Units (PFU) in pre-treatment control samples (grey) and MPLEx-treated samples (red) in infection studies of West Nile (WNV, New York 1999), MERS-CoV (icMERS), Ebola (Ebola-Zaire delta-VP30) and Avian Influenza (H7N9).